Peptides for Covid-19 prevention and treatment
AssigneeSotira Covid, LLC
InventorsAvik Roy, Carl Gunnar Gottschalk
Life of this patent
Estimating the term…
Abstract
Embodiments include therapeutic peptides for preventing or reducing the transmission of a coronavirus such as SARS-CoV2. Also included are methods of using therapeutic peptides for reducing or preventing transmission of a coronavirus such as SARS-CoV2. The therapeutic peptides can prevent a region of the surface glycoprotein “spike” on SARS-CoV2 from interacting with angiotensin converting enzyme-2 (ACE-2) of host cells.
Claims5
A method of preventing or treating a Covid-19 infection by blocking interaction with a host cell in a subject, the method comprising administering a therapeutic amount of a peptide of SEQ ID NO:1 to the subject,
- wherein the peptide is administered as a nasal spray or inhalant.
A method of preventing or treating a coronavirus virus infection in a patient, the method comprising administering a therapeutic amount of a peptide of SEQ ID NO:
- 1 to the patient,
- wherein the peptide comprises a carboxy-terminal lysine residue and a biotin residue.
Dependencies are inferred from the claim text.